EXHIBIT 99.1
SCHEDULE A
AGREEMENTS TRANSFERRED
PURSUANT TO THIS AGREEMENT
COMPANY DESCRIPTION DATE TERM
- ------- ----------- ---- ----
International Non-exclusive license and May 3 Years/
Diagnostics marketing agreement concerning 1988 Annual Renewal
Systems equine drugs of abuse reagents Option
Flurotec, Inc. Non-exclusive license agree- October 3 Years/
ment to develop, manufacture 1988 Automatic
and sell assays in the bio- Renewal
technology industrial (non-
clinical) market
Hospital for Feasibility and development April 3 Years
Sick Children funding agreement related to 1988
cellular flourescence biassays
Southern Exclusive supply agreement December 2 1/2 Years
Biotechnology for private label reagents 1987 Expired
Associates and supplies May 1990
Pacific Non-exclusive license agree- Agreement
Diagnostics ment to make, use, and pending
sell products using the Screen signature
Machine/FCA technology in the approval
medical research market in
Australia, New Zealand, and
the Far East.
Chicago Research funding agreement August 6 Months
Medical related to measuring in vitro 1990
School cell-mediated cytotoxicity
using FCA technology.
SCHEDULE C
EXISTING BAXTER SERVICE CONTRACTS AND WARRANTY AGREEMENTS
TRANSFERRED PURSUANT TO THIS AGREEMENT
CUSTOMER INSTRUMENT
- -------- ----------
M.D. Anderson FCA 63
Miami Baptist S/M 38
Miami Baptist FCA 84
Monsanto S/M 115
Affymax S/M 162
U of West Ontario FCA 1054
NIH S/M 54
NIH S/M 104
Abbott S/M 28
Alcon Labs S/M 12
Centocor S/M 20
Mol Biosyst FCA 1022
Genentech S/M 37
Hosp for Sick Children S/M 75
Hosp for Sick Children S/M 101
Hosp for Sick Children FCA 66
Comnaught S/M 110
M.D. Anderson S/M 41
3M Company S/M 59
IDEXX FCA 1041
Henry Jackson FCA 1084
Boehringer S/M 164
U of Alabama S/M 100
U of Minnesota FCA 82
Glaxco FCA 1096
Glaxco FCA 1097
U of Miami FCA 77
Athena S/M 107
Unearned Service Contract Revenue $60,809
@ 7/31/90 =======
90 day warranty on new instruments -
warranty reserve balance @ 7/31/90 $2,583
======